|
Pfizer and BioNTech announce positive topline data for mRNA-based combination vaccine program against influenza and COVID-19
|
30 October 2023 |
|
FDA approves PENBRAYA™, the first and only vaccine for the prevention of the five most common serogroups causing meningococcal disease in adolescents
|
23 October 2023 |
|
U.S. FDA approves Pfizer's BRAFTOVI® + MEKTOVI® for BRAF V600E-mutant metastatic non-small cell lung cancer
|
12 October 2023 |
|
Pfizer presents new data at IDWeek 2023 highlighting advances in prevention and treatment of certain respiratory illnesses and other infectious diseases
|
09 October 2023 |
|
U.S. FDA Approves ABRYSVO™, Pfizer's vaccine for the prevention of respiratory syncytial virus (RSV) in infants through active immunization of pregnant individuals 32-36 weeks of gestational age
|
23 August 2023 |
|
Pfizer's ELREXFIO™ receives U.S. FDA accelerated approval for relapsed or refractory multiple myeloma
|
14 August 2023 |
|
Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries
|
04 August 2023 |
|
Pfizer announces executive leadership to advance oncology research and development strategy
|
27 July 2023 |
|
Pfizer announces New England Journal of Medicine publication on Group B Streptococcus (GBS) maternal vaccine candidate
|
21 July 2023 |
|
Flagship Pioneering and Pfizer partner to accelerate development of innovative medicines targeting unmet needs
|
18 July 2023 |
|
FDA approves Pfizer's NGENLA™, a long-acting once-weekly treatment for pediatric growth hormone deficiency
|
04 July 2023 |
|
FDA accepts Pfizer's application for hemophilia B gene therapy fidanacogene elaparvovec
|
27 June 2023 |
|
FDA approves Pfizer's LITFULO™ (ritlecitinib) for adults and adolescents with severe alopecia areata
|
26 June 2023 |
|
Pfizer's TALZENNA® in combination with XTANDI® receives U.S. FDA approval
|
21 June 2023 |
|
U.S. FDA approves ABRYSVO™, Pfizer's vaccine for the prevention of respiratory syncytial virus (RSV) in older adults
|
01 June 2023 |
|
Pfizer's PAXLOVID™ receives FDA approval for adult patients at high risk of progression to severe COVID-19
|
25 May 2023 |
|
FDA Advisory Committee votes in support of approval for Pfizer's vaccine candidate to help prevent RSV in infants through maternal immunization
|
19 May 2023 |
|
Thermo Fisher Scientific & Pfizer partner to expand localized access to next generation sequencing-based testing for cancer patients in international markets
|
18 May 2023 |
|
U.S. FDA approves PREVNAR 20®, Pfizer's 20-valent pneumococcal conjugate vaccine for infants and children
|
27 April 2023 |
|
FDA accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
|
05 April 2023 |